[1]苏国庆,王凯冰,金书强,等.肝动脉栓塞术中“血管湖”现象的临床初探[J].介入放射学杂志,2019,28(04):335-338.
 SU Guoqing,WANG Kaibing,JIN Shuqiang,et al.Preliminary clinical study on the “vascular lake” phenomenon observed in hepatic artery embolization[J].journal interventional radiology,2019,28(04):335-338.
点击复制

肝动脉栓塞术中“血管湖”现象的临床初探()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
28
期数:
2019年04期
页码:
335-338
栏目:
肿瘤介入
出版日期:
2019-04-25

文章信息/Info

Title:
Preliminary clinical study on the “vascular lake” phenomenon observed in hepatic artery embolization
作者:
苏国庆 王凯冰 金书强 王 憬 李映辰 白 彬
Author(s):
SU Guoqing WANG Kaibing JIN Shuqiang WANG Jing LI Yingchen BAI Bin.
Department of Interventional Radiology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province 150001, China
关键词:
【关键词】 原发性肝癌 化学栓塞 微球 血管湖 疗效
文献标志码:
A
摘要:
【摘要】 目的 探究肝动脉栓塞术中“血管湖”现象的发生机制,研究其与预后关系。方法 回顾性分析2017年3月至2018年3月诊断为原发性肝癌仅使用微球作为栓塞材料的221例患者。根据其术中是否出现“血管湖”现象分为A、B两组。A组33个病灶(32例患者),术中出现“血管湖”现象;B组270个病灶(189例患者),术中未出现“血管湖”现象。结果 “血管湖”现象患者发生率为14.5%(32/221),病灶发生率为10.9%(33/303),该现象发生与肿瘤直径是否≥3 cm、肿瘤是否存在假包膜、单位体积肿瘤所使用的微球量是否≥0.01 mL/cm3之间存在统计学意义(P<0.05)。A、B两组患者预后评估在改良实体瘤疗效评估标准(mRECIST)、总生存率(OR)上差异有统计学意义(P<0.05)。结论 “血管湖”现象的患者发生率为14.5%(32/221),其发生机制可能与肿瘤的大小、肿瘤是否存在假包膜、单位体积肿瘤所使用的微球量有关,该现象的发生可能预示着更好的临床疗效。

参考文献/References:

[1] Liu X, Wang Z, Chen Z, et al. Efficacy and safety of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion in hepatocellular carcinoma: a systematic review and meta- analysis[J]. Oncol Res, 2018, 26: 231- 239.
[2] 葛均波, 徐永健. 内科学[M]. 北京: 人民卫生出版社, 2013.
[3] Thayer D, Noda C, Charalel R, et al. Survival comparison of hepatocellular carcinoma patients treated with radioembolization versus nonoperative/interventional treatment[J]. J Comp Eff Res, 2018, 7: 343- 356.
[4] Cavalcante RN, Nasser F, Mottalealfilho JM, et al. Occurrence of vascular lake phenomenon as a predictor of improved tumor response in HCC patients that underwent DEB- TACE[J]. Cardiovasc Intervent Radiol, 2017, 40: 1044- 1051.
[5] Seki A, Hori S, Shimono C. Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres[J]. Jpn J Radiol, 2015, 33: 741- 748.
[6] 李功杰, 杨 立, 史晓林, 等. 原发性肝癌肿瘤新生血管形态特征与其DSA血供分型关系的研究[J]. 介入放射学杂志, 2005, 14: 135- 138.
[7] Yamanaka J, Yamanaka N, Nakasho K, et al. Clinicopathologic analysis of stage Ⅱ- Ⅲ hepatocellular carcinoma showing early massive recurrence after liver resection[J]. J Gastroenterol Hepatol, 2000, 15: 1192- 1198.

相似文献/References:

[1]高 嵩,朱旭,杨仁杰,等. TACE联合奥沙利铂、氟尿嘧啶、亚叶酸钙肝动脉化疗治疗中晚期原发性肝癌[J].介入放射学杂志,2012,(05):377.
 ,,et al. TACE combined with hepatic arterial infusion chemotherapy using oxaliplatin, 5fluorouracil and folinic acid for intermediate and advanced hepatocellular carcinomas[J].journal interventional radiology,2012,(04):377.
[2]程洪涛,郭晨阳,黎海亮,等.TACE联合射频消融治疗原发性肝癌疗效的影响因素分析[J].介入放射学杂志,2012,(03):216.
 ,,et al.TACE combined with CTguided percutaneous radiofrequency ablation for the treatment of primary hepatocellular carcinomas: an analysis of factors affecting the therapeutic result [J].journal interventional radiology,2012,(04):216.
[3]张晓前,郭 鹏,党之俊,等.金龙胶囊联合介入疗法治疗原发性肝癌临床观察[J].介入放射学杂志,2012,(03):249.
 ,,et al.Kinglong capsules combined with interventional therapy for hepatocellular carcinomas: clinical observation [J].journal interventional radiology,2012,(04):249.
[4]姚红响,陈根生,诸葛英,等.肝动脉化疗栓塞联合CT引导射频消融序贯治疗中小肝癌的临床应用[J].介入放射学杂志,2012,(04):301.
 ,,et al.Sequential treatment with TACE and CTguided RFA for small and moderate sized HCC [J].journal interventional radiology,2012,(04):301.
[5]姚全军,胡鸿涛,黎海亮,等.C臂CT成像在乏血供原发性肝癌诊疗中的临床应用[J].介入放射学杂志,2012,(04):305.
 ,,et al.The clinical application of C arm CT imaging in diagnosing and treating hypovascular primary hepatic carcinomas [J].journal interventional radiology,2012,(04):305.
[6]刘 昕,吕维富,鲁 东,等. 动脉介入栓塞治疗肝癌破裂出血[J].介入放射学杂志,2012,(07):586.
 LIU Xin,LV Wei- fu,LU Dong,et al. Interventional treatment of hepatic bleeding due to spontaneous rupture of hepatocellular carcinoma[J].journal interventional radiology,2012,(04):586.
[7]张志良,杨学东,温阿明,等. 经动脉化疗栓塞联合伽玛刀治疗原发性肝癌的疗效评价[J].介入放射学杂志,2012,(07):596.
 ZHANG Zhi- liang,YANG Xue- dong,WEN A-ming,et al. Evaluation of TACE combined with gamma?蛳 knife radiotherapy for primary hepatocellular carcinoma[J].journal interventional radiology,2012,(04):596.
[8]赵许亚,周 石.TACE联合经皮瘤内注射碘油吡柔比星乳剂治疗中晚期肝癌疗效分析[J].介入放射学杂志,2012,(08):675.
 ZHAO Xu- ya,ZHOU Shi.. Transcatheter artery chemoembolization combined with percutaneous intratumoral injection of Lipiodol emulsion of pirarubicin for advanced hepatocellular carcinomas: an analysis of clinical efficacy[J].journal interventional radiology,2012,(04):675.
[9]王少雷,李 森,魏 宏,等.奥沙利铂与吡喃阿霉素介入治疗原发性肝癌的比较研究[J].介入放射学杂志,2012,(09):738.
 WANG Shao- lei,LI Sen,WEI Hong,et al. Interventional chemoembolization therapy of primary hepatocellular carcinoma: a comparative study between oxaliplatin and therarubicin[J].journal interventional radiology,2012,(04):738.
[10]骆俊朋,胡鸿涛,郭晨阳,等.吉西他滨热化疗灌注联合卡铂化疗栓塞治疗原发性肝癌临床应用研究[J].介入放射学杂志,2013,(06):470.
 LUO Jun? peng,HU Hong? tao,GUO Chen? yang,et al. Hyperthermochemotherapy by using heated gemcitabine perfusion combined with transcatheter arterial chemoembolization of carboplatin for primary liver carcinomas[J].journal interventional radiology,2013,(04):470.

备注/Memo

备注/Memo:
(收稿日期:2018-07-10)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2019-04-09